240 related articles for article (PubMed ID: 27605628)
1. Long-Term Reduction of Kappa Opioid Receptor Function by the Biased Ligand, Norbinaltorphimine, Requires c-Jun N-Terminal Kinase Activity and New Protein Synthesis in Peripheral Sensory Neurons.
Jamshidi RJ; Sullivan LC; Jacobs BA; Chavera TA; Berg KA; Clarke WP
J Pharmacol Exp Ther; 2016 Nov; 359(2):319-328. PubMed ID: 27605628
[TBL] [Abstract][Full Text] [Related]
2. 14-3-3γ mediates the long-term inhibition of peripheral kappa opioid receptor antinociceptive signaling by norbinaltorphimine.
Wedemeyer MJ; Jennings EM; Smith HR; Chavera TS; Jamshidi RJ; Berg KA; Clarke WP
Neuropharmacology; 2022 Dec; 220():109251. PubMed ID: 36126728
[TBL] [Abstract][Full Text] [Related]
3. Functional selectivity of kappa opioid receptor agonists in peripheral sensory neurons.
Jamshidi RJ; Jacobs BA; Sullivan LC; Chavera TA; Saylor RM; Prisinzano TE; Clarke WP; Berg KA
J Pharmacol Exp Ther; 2015 Nov; 355(2):174-82. PubMed ID: 26297384
[TBL] [Abstract][Full Text] [Related]
4. Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase.
Bruchas MR; Yang T; Schreiber S; Defino M; Kwan SC; Li S; Chavkin C
J Biol Chem; 2007 Oct; 282(41):29803-11. PubMed ID: 17702750
[TBL] [Abstract][Full Text] [Related]
5. Reactive oxygen species (ROS) generation is stimulated by κ opioid receptor activation through phosphorylated c-Jun N-terminal kinase and inhibited by p38 mitogen-activated protein kinase (MAPK) activation.
Schattauer SS; Bedini A; Summers F; Reilly-Treat A; Andrews MM; Land BB; Chavkin C
J Biol Chem; 2019 Nov; 294(45):16884-16896. PubMed ID: 31575661
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Kappa Opioid Receptor Inactivation Depends on Sex and Cellular Site of Antagonist Action.
Reichard KL; Newton KA; Rivera ZMG; Sotero de Menezes PM; Schattauer SS; Land BB; Chavkin C
Mol Pharmacol; 2020 Nov; 98(5):548-558. PubMed ID: 32913138
[TBL] [Abstract][Full Text] [Related]
7. Regulation of δ Opioid Receptor-Mediated Signaling and Antinociception in Peripheral Sensory Neurons by Arachidonic Acid-Dependent 12/15-Lipoxygenase Metabolites.
Sullivan LC; Chavera TA; Gao X; Pando MM; Berg KA
J Pharmacol Exp Ther; 2017 Jul; 362(1):200-209. PubMed ID: 28465374
[TBL] [Abstract][Full Text] [Related]
8. Effects of a post-shock injection of the kappa opioid receptor antagonist norbinaltorphimine (norBNI) on fear and anxiety in rats.
Rogala B; Li Y; Li S; Chen X; Kirouac GJ
PLoS One; 2012; 7(11):e49669. PubMed ID: 23166745
[TBL] [Abstract][Full Text] [Related]
9. Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinase.
Xu M; Bruchas MR; Ippolito DL; Gendron L; Chavkin C
J Neurosci; 2007 Mar; 27(10):2570-81. PubMed ID: 17344394
[TBL] [Abstract][Full Text] [Related]
10. Effect of norbinaltorphimine on ∆⁹-tetrahydrocannabinol (THC)-induced taste avoidance in adolescent and adult Sprague-Dawley rats.
Flax SM; Wakeford AG; Cheng K; Rice KC; Riley AL
Psychopharmacology (Berl); 2015 Sep; 232(17):3193-201. PubMed ID: 26025420
[TBL] [Abstract][Full Text] [Related]
11. Allosterism within
Jacobs BA; Pando MM; Jennings E; Chavera TA; Clarke WP; Berg KA
Mol Pharmacol; 2018 Apr; 93(4):376-386. PubMed ID: 29436492
[TBL] [Abstract][Full Text] [Related]
12. Kappa opioid receptor activation decreases inhibitory transmission and antagonizes alcohol effects in rat central amygdala.
Gilpin NW; Roberto M; Koob GF; Schweitzer P
Neuropharmacology; 2014 Feb; 77():294-302. PubMed ID: 24157490
[TBL] [Abstract][Full Text] [Related]
13. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
[TBL] [Abstract][Full Text] [Related]
14. Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor.
Schattauer SS; Kuhar JR; Song A; Chavkin C
Cell Signal; 2017 Apr; 32():59-65. PubMed ID: 28088389
[TBL] [Abstract][Full Text] [Related]
15. Nor-Binaltorphimine Blocks the Adverse Effects of Morphine after Spinal Cord Injury.
Aceves M; Bancroft EA; Aceves AR; Hook MA
J Neurotrauma; 2017 Mar; 34(6):1164-1174. PubMed ID: 27736318
[TBL] [Abstract][Full Text] [Related]
16. Allosteric interactions between δ and κ opioid receptors in peripheral sensory neurons.
Berg KA; Rowan MP; Gupta A; Sanchez TA; Silva M; Gomes I; McGuire BA; Portoghese PS; Hargreaves KM; Devi LA; Clarke WP
Mol Pharmacol; 2012 Feb; 81(2):264-72. PubMed ID: 22072818
[TBL] [Abstract][Full Text] [Related]
17. Major effect of pyrrolic N-benzylation in norbinaltorphimine, the selective kappa-opioid receptor antagonist.
Chauvignac C; Miller CN; Srivastava SK; Lewis JW; Husbands SM; Traynor JR
J Med Chem; 2005 Mar; 48(5):1676-9. PubMed ID: 15743210
[TBL] [Abstract][Full Text] [Related]
18. Regulation of κ-opioid receptor signaling in peripheral sensory neurons in vitro and in vivo.
Berg KA; Rowan MP; Sanchez TA; Silva M; Patwardhan AM; Milam SB; Hargreaves KM; Clarke WP
J Pharmacol Exp Ther; 2011 Jul; 338(1):92-9. PubMed ID: 21487072
[TBL] [Abstract][Full Text] [Related]
19. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.
Zhou L; Stahl EL; Lovell KM; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
Neuropharmacology; 2015 Dec; 99():131-41. PubMed ID: 26160155
[TBL] [Abstract][Full Text] [Related]
20. Difelikefalin, a peripherally restricted KOR (kappa opioid receptor) agonist, produces diuresis through a central KOR pathway.
Meariman JK; Sutphen JC; Gao J; Mercante DE; Kapusta DR
Pharmacol Res; 2022 Nov; 185():106470. PubMed ID: 36202183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
